These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma. Pföhler C; Haus A; Palmowski A; Ugurel S; Ruprecht KW; Thirkill CE; Tilgen W; Reinhold U Br J Dermatol; 2003 Jul; 149(1):74-8. PubMed ID: 12890197 [TBL] [Abstract][Full Text] [Related]
6. [Melanoma-associated retinopathy. Apropos of a case and review of the literature]. Bret-Dibat C; Rougier MB; Le Rebeller MJ; Delaunay M Bull Cancer; 1996 Dec; 83(12):1019-22. PubMed ID: 9116366 [TBL] [Abstract][Full Text] [Related]
7. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Lei B; Bush RA; Milam AH; Sieving PA Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629 [TBL] [Abstract][Full Text] [Related]
8. Full-field electroretinogram in a patient with cutaneous melanoma-associated retinopathy. Andréasson S; Ponjavic V; Ehinger B Acta Ophthalmol (Copenh); 1993 Aug; 71(4):487-90. PubMed ID: 8249579 [TBL] [Abstract][Full Text] [Related]
9. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression. Karatsai E; Robson AG; Taylor SRJ JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772 [TBL] [Abstract][Full Text] [Related]
10. Unilateral manifestation of melanoma-associated retinopathy. Janáky M; Pálffy A; Kolozsvári L; Benedek G Arch Ophthalmol; 2002 Jun; 120(6):866-7. PubMed ID: 12049605 [No Abstract] [Full Text] [Related]
11. Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy. Alexander KR; Barnes CS; Fishman GA; Milam AH Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1189-97. PubMed ID: 11923265 [TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic retinopathy associated with cutaneous melanoma. An update apropos of a case]. Rougier MB; Hostyn P; Bret-Dibat C; Delaunay MM; Riss I; Le Rebeller MJ J Fr Ophtalmol; 1995; 18(5):396-403. PubMed ID: 7560778 [TBL] [Abstract][Full Text] [Related]
13. Node way out. Vaphiades MS; Brown H; Whitcup SM Surv Ophthalmol; 2000; 45(1):77-83. PubMed ID: 10946083 [TBL] [Abstract][Full Text] [Related]
14. Melanoma-associated retinopathy versus abnormal retinal function due to interferon-alpha/Isotretinoin therapy in cutaneous malignant melanoma. Feigl B; Faschinger C; Soyer P Ophthalmologica; 2000; 214(4):271-6. PubMed ID: 10859510 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Potter MJ; Adamus G; Szabo SM; Lee R; Mohaseb K; Behn D Am J Ophthalmol; 2002 Jul; 134(1):128-30. PubMed ID: 12095824 [TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic night blindness with malignant melanoma. Berson EL; Lessell S Am J Ophthalmol; 1988 Sep; 106(3):307-11. PubMed ID: 2971322 [TBL] [Abstract][Full Text] [Related]